Header Logo

Rebecca

Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Boyles T, Berhanu RH, Gogela N, Gunter H, Lovelock T, Mphothulo N, Parker A, Rabie H, Richards L, Sinxadi P, Wattrus C, Moosa MY. Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update. South Afr J HIV Med. 2024; 25(1):1558. PMID: 38628909; PMCID: PMC11019071.
      Citations:    
    2. Koethe JR, Eeds A, Stewart LV, Haas DW, Hildreth JEK, Mallal S, Wanjalla C, Perkins J, Ahonkhai A, Dong X, Berhanu R, Dash C. The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes. J Acquir Immune Defic Syndr. 2023 10 01; 94(2S):S42-S46. PMID: 37707847; PMCID: PMC10503046.
      Citations: 1     Fields:    Translation:Humans
    3. Martinson NA, Nonyane BAS, Genade LP, Berhanu RH, Naidoo P, Brey Z, Kinghorn A, Nyathi S, Young K, Hausler H, Connell L, Lutchminarain K, Swe Swe-Han K, Vreede H, Said M, von Knorring N, Moulton LH, Lebina L, TUTT Trial team. Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial). PLoS Med. 2023 05; 20(5):e1004237. PMID: 37216385; PMCID: PMC10263318.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    4. Berhanu RH, Lebina L, Nonyane BAS, Milovanovic M, Kinghorn A, Connell L, Nyathi S, Young K, Hausler H, Naidoo P, Brey Z, Shearer K, Genade L, Martinson NA. Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa. Clin Infect Dis. 2023 05 03; 76(9):1594-1603. PMID: 36610730; PMCID: PMC10156124.
      Citations: 5     Fields:    Translation:HumansCells
    5. Audet CM, Seabi T, Ngobeni S, Berhanu RH, Wagner RG. Pulmonary tuberculosis vs. Tindzhaka and Mafularha: A mixed methods inquiry of traditional healers' perceptions of tuberculosis in rural South Africa. PLOS Glob Public Health. 2023; 3(4):e0001611. PMID: 37083848; PMCID: PMC10121049.
      Citations:    
    6. Berhanu RH, Jacobson KR. Tuberculosis Preventive Therapy for People With HIV Infection in High Tuberculosis Burden Settings: How Much Is Enough? Ann Intern Med. 2021 10; 174(10):1462-1463. PMID: 34424729.
      Citations:    Fields:    Translation:Humans
    7. Mokhele I, Jinga N, Berhanu R, Dlamini T, Long L, Evans D. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa. BMC Pregnancy Childbirth. 2021 Jun 28; 21(1):453. PMID: 34182944; PMCID: PMC8240388.
      Citations: 9     Fields:    Translation:Humans
    8. Masuku SD, Berhanu R, Van Rensburg C, Ndjeka N, Rosen S, Long L, Evans D, Nichols BE. Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis. Int J Tuberc Lung Dis. 2020 04 01; 24(4):376-382. PMID: 32317060; PMCID: PMC7656447.
      Citations: 5     Fields:    Translation:Humans
    9. Jamieson L, Evans D, Berhanu R, Ismail N, Aucock S, Wallengren K, Long L. Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa. BMC Public Health. 2019 Dec 05; 19(1):1638. PMID: 31805982; PMCID: PMC6896407.
      Citations: 5     Fields:    Translation:Humans
    10. Berry KM, Rodriguez CA, Berhanu RH, Ismail N, Mvusi L, Long L, Evans D. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa. BMC Public Health. 2019 Jul 22; 19(1):973. PMID: 31331311; PMCID: PMC6647101.
      Citations: 19     Fields:    Translation:Humans
    11. van Rensburg C, Berhanu R, Hirasen K, Evans D, Rosen S, Long L. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2019; 14(6):e0217820. PMID: 31170207; PMCID: PMC6553851.
      Citations: 6     Fields:    Translation:Humans
    12. Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N, Lönnmark E, Long L, Rosen S. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes. 2019 May 31; 17(1):94. PMID: 31151398; PMCID: PMC6545023.
      Citations: 16     Fields:    Translation:Humans
    13. Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis. 2019 03 01; 23(3):358-362. PMID: 30940300; PMCID: PMC6495054.
      Citations: 12     Fields:    Translation:HumansCells
    14. Evans D, Sineke T, Schnippel K, Berhanu R, Govathson C, Black A, Long L, Rosen S. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Serv Res. 2018 Dec 17; 18(1):973. PMID: 30558670; PMCID: PMC6296148.
      Citations: 21     Fields:    Translation:HumansCells
    15. Berhanu RH, David A, da Silva P, Shearer K, Sanne I, Stevens W, Scott L. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. J Clin Microbiol. 2018 12; 56(12). PMID: 30305387; PMCID: PMC6258835.
      Citations: 26     Fields:    Translation:HumansCells
    16. Hirasen K, Berhanu R, Evans D, Rosen S, Sanne I, Long L. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463. PMID: 30300403; PMCID: PMC6177165.
      Citations: 5     Fields:    Translation:Humans
    17. Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? Int J Tuberc Lung Dis. 2018 08 01; 22(8):358-362. PMID: 29991400; PMCID: PMC6421943.
      Citations: 9     Fields:    Translation:Humans
    18. Evans D, Hirasen K, Berhanu R, Malete G, Ive P, Spencer D, Badal-Faesen S, Sanne IM, Fox MP. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa. AIDS Res Ther. 2018 04 10; 15(1):10. PMID: 29636106; PMCID: PMC5891887.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    19. Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E. Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa. Int J Tuberc Lung Dis. 2018 04 01; 22(4):393-398. PMID: 29562986.
      Citations: 6     Fields:    Translation:Humans
    20. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):413-416. PMID: 29206723; PMCID: PMC5825249.
      Citations: 1     Fields:    Translation:Humans
    21. Evans D, Dahlberg S, Berhanu R, Sineke T, Govathson C, Jonker I, Lönnermark E, Fox MP. Social and behavioral factors associated with failing second-line ART - results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa. AIDS Care. 2018 07; 30(7):863-870. PMID: 29463102; PMCID: PMC7317067.
      Citations: 5     Fields:    Translation:Humans
    22. Nel JS, Lippincott CK, Berhanu R, Spencer DC, Sanne IM, Ive P. Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review. Clin Infect Dis. 2017 10 01; 65(7):1226-1228. PMID: 28575238.
      Citations: 9     Fields:    Translation:HumansCells
    23. Schnippel K, Firnhaber C, Ndjeka N, Conradie F, Page-Shipp L, Berhanu R, Sinanovic E. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1106-1111. PMID: 28911353.
      Citations: 8     Fields:    Translation:Humans
    24. Evans D, Schnippel K, Govathson C, Sineke T, Black A, Long L, Berhanu R, Rosen S. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2017; 12(7):e0181238. PMID: 28746344; PMCID: PMC5529007.
      Citations: 6     Fields:    Translation:HumansCells
    25. Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E. Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis. J Antimicrob Chemother. 2017 07 01; 72(7):1871-1879. PMID: 28419314.
      Citations: 26     Fields:    Translation:Humans
    26. Onoya D, Brennan AT, Berhanu R, van der Berg L, Buthelezi T, Fox MP. Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa. J Int AIDS Soc. 2016 12 22; 19(1):20675. PMID: 28364563; PMCID: PMC5463878.
      Citations: 4     Fields:    Translation:Humans
    27. Shearer K, Evans D, Moyo F, Rohr JK, Berhanu R, Van Den Berg L, Long L, Sanne I, Fox MP. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa. Trop Med Int Health. 2017 02; 22(2):221-231. PMID: 27797443; PMCID: PMC5288291.
      Citations: 9     Fields:    Translation:Humans
    28. Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974. PMID: 27812140; PMCID: PMC5094796.
      Citations: 7     Fields:    Translation:Humans
    29. Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MP. Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS Behav. 2016 11; 20(11):2717-2728. PMID: 27146828; PMCID: PMC5069329.
      Citations: 15     Fields:    Translation:Humans
    30. Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study. BMC Infect Dis. 2016 Oct 21; 16(1):593. PMID: 27769174; PMCID: PMC5073931.
      Citations: 15     Fields:    Translation:Humans
    31. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa. J Int AIDS Soc. 2016; 19(1):20987. PMID: 27677395; PMCID: PMC5039239.
      Citations: 15     Fields:    
    32. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS One. 2016; 11(8):e0161469. PMID: 27548695; PMCID: PMC4993510.
      Citations: 29     Fields:    Translation:HumansCells
    33. Gajee R, Schnippel K, Mthupha N, Muzah B, Berhanu R. Missed appointments among rifampicin-resistant tuberculosis (RR-TB) patients at a decentralised RR-TB outpatient clinic in Johannesburg, South Africa. S Afr Med J. 2016 Aug 07; 106(9):912-7. PMID: 27601119.
      Citations: 5     Fields:    
    34. Brennan AT, Bonawitz R, Schnippel K, Berhanu R, Maskew M, Long L, Bassett J, Sanne I, Fox MP. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa. Int J Tuberc Lung Dis. 2016 08; 20(8):1040-5. PMID: 27393537.
      Citations: 7     Fields:    Translation:Humans
    35. Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health. 2016 09; 21(9):1131-7. PMID: 27383454.
      Citations: 31     Fields:    Translation:HumansCells
    36. Schnippel K, Ndjeka N, Conradie F, Berhanu R, Claasen Z, Banoo S, Firnhaber C. A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis. S Afr Med J. 2016 Mar 17; 106(4):30-1. PMID: 27032841.
      Citations: 6     Fields:    Translation:Humans
    37. Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Int J Infect Dis. 2015 Oct; 39:89-94. PMID: 26358856.
      Citations: 20     Fields:    Translation:Humans
    38. d'Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. Pan Afr Med J. 2015; 22:4. PMID: 26600904; PMCID: PMC4643149.
      Citations: 5     Fields:    Translation:Humans
    39. Naidoo S, Evans D, Jong E, Mellet K, Berhanu R. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury. S Afr Med J. 2015 Apr 07; 105(5):393-6. PMID: 26242667.
      Citations: 4     Fields:    Translation:Humans
    40. Shearer K, Brennan AT, Maskew M, Long L, Berhanu R, Sanne I, Fox MP. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. J Int AIDS Soc. 2014; 17:19065. PMID: 25361827; PMCID: PMC4215701.
      Citations: 11     Fields:    Translation:HumansCells
    41. Shearer K, Maskew M, Ajayi T, Berhanu R, Majuba P, Sanne I, Fox MP. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis. 2014 Jun; 23:56-62. PMID: 24680820; PMCID: PMC4092228.
      Citations: 13     Fields:    Translation:Humans
    42. Shearer K, Fox MP, Maskew M, Berhanu R, Long L, Sanne I. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa. PLoS One. 2013; 8(8):e71719. PMID: 23940782; PMCID: PMC3737125.
      Citations: 8     Fields:    Translation:Humans
    Berhanu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (139)
    Explore
    _
    Co-Authors (23)
    Explore
    _
    Similar People (60)
    Explore
    _